Tenon Medical Inc (TNON) shares surged by a remarkable 21.3% to $6.10 during Friday’s trading session, fueled by the company’s announcement of receiving three patent approvals from the United States Patent and Trademark Office (USPTO). These patents represent significant advancements in SI joint prostheses, particularly in drug delivery systems that promote bone growth and innovative designs addressing challenges related to failed SI joint stabilizations.
The granted patents, expected to be officially issued within the next 90 days, will substantially enhance Tenon Medical’s existing patent portfolio, which already boasts nine previously issued U.S. and international patents, alongside 26 pending applications. According to Richard Ginn, Tenon Medical’s Chief Technology Officer, this expanding intellectual property portfolio is a cornerstone of the company’s strategy to broaden the commercialization of its Catamaran SI Joint Fusion System.
Furthermore, Tenon Medical has recently filed additional patent applications, demonstrating its commitment to developing improved solutions for SI joint stabilization. This dedication to innovation and protection of intellectual property suggests a promising future for the company’s growth and market position.
For investors keen on participating in Tenon Medical’s journey, buying shares is typically accomplished through a brokerage account. A variety of trading platforms offer access to the stock market, and many allow for the purchase of ‘fractional shares,’ enabling investors to own portions of stock without buying an entire share. This is particularly beneficial for stocks like Berkshire Hathaway or Amazon.com, which can have high share prices.
If you’re seeking to bet against the company, the process becomes more complex. This involves accessing an options trading platform or a broker who allows ‘short selling’ – lending shares to sell and hoping for a price decline. Engaging in short selling requires thorough understanding and carries its own set of risks. Alternatively, options trading offers strategies like buying a put option or selling a call option, both enabling profit from a potential share price decline.
It’s important to remember that this information is for educational purposes only and does not constitute investment advice. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.
